Possible remedy for the rejection of an organ transplant


Cannabis THC proves to be a possible cure for rejection of an organ transplant

In recent weeks, scientists who have been studying the therapeutic effects of cannabis have made a number of remarkable discoveries. Including a potential solution for rejection of transplanted organs. Thus, this discovery could revolutionize surgery, during an organ transplant.

THC helps prevent rejection of incompatible organs

Researchers at the University of South Carolina's Faculty of Medicine are discovering that, when mice are given THC - the active ingredient in cannabis - the cannabinoid appears to help prevent the rejection of incompatible organs. It's a huge step forward! Because according to theStanford University School of Medicine, a quarter of renal transplant recipients and about 40% of heart transplant patients organ rejection in the first year ... This, coupled with the difficulty of finding viable organs to transplant, means that anything that reduces the rejection rate would immediately become a coveted medical discovery.

"We are excited to demonstrate for the first time that cannabinoid receptors play an important role. In particular, in the extension of the rejection of a foreign transplant. This by suppressing the immune response of the recipient. "Mitzi Nagarkatti, Ph.D, is responsible for the study. "This opens up a new area of ​​research that would lead to better approaches to prevent rejection of transplants. As well as to treat other inflammatory diseases. "

Scientists at the University of South Carolina have described their findings in a standard language: that more research is needed to verify their results. Nevertheless, their initial results provide at least some evidence that THC may be useful in anti-rejection therapy. And especially in cases where organs and recipients are not perfectly compatible.

Read also
The CBD oil revolution among these suburban mothers

Details of the study

To conduct their study, Nagarkatti and his colleagues used two groups of mice. These were genetically different. Thus, the skin has been transplanted from one group to another. And all the mice received incompatible skin transplants ... However, one group received a placebo, while the other received THC. The researchers then observed that skin graft rejection in mice that received THC was delayed compared to the control group that received placebo.

"More and more research is identifying the potential beneficial effects of substances in marijuana. But a major challenge has been to identify the molecular pathways involved. "Note John Wherry, Ph.D., associate editor of the Journal of Leukocyte Biology.

Many studies seem to indicate more important roles for cannabinoid receptors in the body. Thus, they could further adjust how medical science views the therapeutic uses of substances found in cannabis.

Medical advances in therapeutic cannabis

Tags : MedicineSearchTHC